Wunderlich Capital Managemnt Regeneron Pharmaceuticals, Inc. Transaction History

Wunderlich Capital Managemnt

$212 Million
Q2 2024

A detailed history of Wunderlich Capital Managemnt transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wunderlich Capital Managemnt holds 3,764 shares of REGN stock, worth $2.85 Million. This represents 1.87% of its overall portfolio holdings.

Number of Shares

3,764

Previous 3,811 1.23%

Holding current value

$2.85 Million

Previous $3.67 Million 7.85%

% of portfolio

1.87%

Previous 1.73%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $41,510 - $50,345	-47 Reduced 1.23%	3,764 $3.96 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $245,531 - $270,191	-272 Reduced 6.66%	3,811 $3.67 Million
Q4 2023 Feb 15, 2024	SELL	$775.18 - $881.7 $106,199 - $120,792	-137 Reduced 3.25%	4,083 $3.59 Million
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $517,260 - $630,744	747 Added 21.51%	4,220 $3.47 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $542,188 - $661,141	-783 Reduced 18.4%	3,473 $3.47 Million
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $27,301 - $32,383	-39 Reduced 0.91%	4,256 $3.06 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $35,385 - $43,002	-52 Reduced 1.2%	4,295 $3.53 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $84,706 - $91,966	-120 Reduced 2.69%	4,347 $3.14 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $30,420 - $38,388	53 Added 1.2%	4,467 $3.08 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $8,225 - $11,082	15 Added 0.34%	4,414 $2.61 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $23,209 - $27,238	-39 Reduced 0.88%	4,399 $3.07 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $25,000 - $30,864	46 Added 1.05%	4,438 $2.8 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $574 - $680	1 Added 0.02%	4,392 $2.66 Million
Q2 2021 Aug 17, 2021	SELL	$472.8 - $558.54 $3,782 - $4,468	-8 Reduced 0.18%	4,391 $2.45 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $37,078 - $45,500	-83 Reduced 1.85%	4,399 $2.08 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $11,479 - $14,591	24 Added 0.54%	4,482 $2.17 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $81,167 - $98,073	-149 Reduced 3.23%	4,458 $2.5 Million
Q2 2020 Aug 17, 2020	SELL	$493.32 - $643.92 $94,717 - $123,632	-192 Reduced 4.0%	4,607 $2.87 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $48,409 - $71,197	-144 Reduced 2.91%	4,799 $2.34 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $5,756 - $7,906	21 Added 0.43%	4,943 $1.86 Million
Q3 2019 Nov 15, 2019	BUY	$273.46 - $318.39 $21,603 - $25,152	79 Added 1.63%	4,922 $1.37 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $65,612 - $90,845	219 Added 4.74%	4,843 $1.52 Million
Q1 2019 May 16, 2019	BUY	$372.08 - $439.57 $20,836 - $24,615	56 Added 1.23%	4,624 $1.9 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $3,694 - $4,433	-11 Reduced 0.24%	4,568 $1.71 Million
Q3 2018 Nov 15, 2018	SELL	$351.14 - $408.51 $88,136 - $102,536	-251 Reduced 5.2%	4,579 $1.85 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.37 Million - $1.67 Million	4,830 New	4,830 $1.67 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

News

Stay updated on Wunderlich Capital Managemnt with notifications on news.

Account

Wunderlich Capital Managemnt Regeneron Pharmaceuticals, Inc. Transaction History